Pregabalin (brand name Lyrica) is prescribed for nerve pain, fibromyalgia, and certain types of seizures. It’s FDA-approved for five specific conditions, though doctors also prescribe it off-label for a handful of others. The medication works by calming overactive nerve signals, which makes it useful across a surprisingly wide range of problems that share that underlying issue.
FDA-Approved Uses
Pregabalin has five official approvals from the FDA:
- Diabetic nerve pain (diabetic peripheral neuropathy): the burning, tingling, or stabbing pain that develops in the hands and feet when diabetes damages nerves over time.
- Postherpetic neuralgia: lingering nerve pain that persists after a shingles outbreak has healed. This can last months or years and is often described as a deep aching or sharp, shooting pain along the skin where the rash appeared.
- Spinal cord injury pain: chronic nerve pain that develops after damage to the spinal cord.
- Fibromyalgia: widespread musculoskeletal pain accompanied by fatigue, sleep problems, and cognitive difficulties. Pregabalin was actually the first medication approved specifically for fibromyalgia in the U.S.
- Partial-onset seizures: used alongside other seizure medications (not alone) in patients 1 month of age and older.
The common thread across most of these conditions is nerve signaling gone wrong. Damaged or dysfunctional nerves fire too frequently, sending pain signals or triggering seizure activity. Pregabalin targets that overactivity directly.
How Pregabalin Works
Pregabalin attaches to a specific part of nerve cells called the alpha-2-delta subunit on calcium channels. In practical terms, when nerves become overexcited (from damage, disease, or other causes), they release too many chemical signals. Pregabalin reduces the flow of calcium into those nerve endings, which dials back the release of those excitatory chemicals. One notable feature is that it’s state-dependent: it primarily affects nerves that are already overactive, leaving normal nerve function relatively untouched. This selectivity helps explain why it can reduce pain and seizure activity without completely numbing sensation or shutting down brain function.
How Well It Works for Nerve Pain
In clinical trials for diabetic nerve pain, 39% of patients taking pregabalin at 600 mg per day saw their pain cut in half or more, compared to 15% on placebo. That’s a meaningful difference, though it also means the majority of patients didn’t reach that threshold. Looking at broader measures of improvement, 85% of patients on pregabalin reported at least some benefit, versus 47% on placebo.
For fibromyalgia, high-quality evidence supports pain reduction at daily doses of 300 mg, 450 mg, and 600 mg. European guidelines give pregabalin a “weak recommendation” for fibromyalgia, placing it on roughly equal footing with other approved options. It’s generally considered one tool among several rather than a standout treatment for the condition.
Off-Label Prescriptions
Doctors frequently prescribe pregabalin for conditions beyond its five approved uses. Generalized anxiety disorder is one of the most common. Pregabalin is actually approved for anxiety in Europe, though the FDA has not granted that approval in the United States. The same mechanism that quiets overactive pain nerves also appears to reduce the excessive nerve signaling involved in anxiety.
Restless legs syndrome is another off-label use with growing clinical support. In a 12-week trial, 63% of patients taking pregabalin achieved symptom remission, compared to 29% on placebo. The number of involuntary leg movements per hour also improved significantly. Pregabalin is typically considered for restless legs when first-line treatments aren’t providing enough relief or are causing side effects.
Common Side Effects
Dizziness and drowsiness are by far the most frequent side effects, and they show up across every condition pregabalin is prescribed for. In fibromyalgia trials, 38% of patients reported dizziness (versus 9% on placebo) and 20% reported drowsiness (versus 4% on placebo). The rates are somewhat lower for diabetic nerve pain, at 21% and 12% respectively, but still substantial.
Other common side effects include dry mouth, blurred vision, weight gain, swelling in the hands or feet, and difficulty concentrating. Weight gain affected about 11-12% of patients in seizure and fibromyalgia trials, compared to 1-2% on placebo. These side effects tend to be dose-dependent, meaning higher doses bring a greater chance of experiencing them.
In pooled clinical trials, 14% of patients on pregabalin stopped taking it because of side effects, compared to 7% on placebo. Dizziness and drowsiness were the two reasons most responsible for people quitting the medication, each accounting for about 4% of discontinuations.
Dependence and Tapering
Pregabalin is classified as a Schedule V controlled substance, the lowest level of federal scheduling. This classification reflects a real, if relatively modest, potential for misuse. In a study of recreational drug users, a single 450 mg dose of pregabalin produced feelings of euphoria and a “high” comparable to a moderate dose of diazepam (Valium). In broader clinical trials, about 4% of patients reported euphoria as a side effect, though in certain populations that number climbed as high as 12%.
Physical dependence can develop with regular use. Stopping pregabalin abruptly may cause insomnia, nausea, headache, or diarrhea. The recommended approach is to taper gradually over at least one week rather than stopping all at once.
How It Compares to Gabapentin
Pregabalin and gabapentin are closely related medications that work through the same mechanism, but they differ in one important practical way: absorption. Pregabalin has a bioavailability of 90% or higher regardless of dose, meaning your body absorbs nearly all of what you take. Gabapentin’s bioavailability drops from 60% down to 33% as the dose increases, which makes it harder to predict how much is actually getting into your system at higher doses.
Pregabalin also reaches peak blood levels within about one hour, compared to three to four hours for gabapentin. These pharmacological advantages mean pregabalin’s effects are more predictable and consistent across different doses, which can matter for conditions requiring precise dosing like seizure management.
Typical Dosing Ranges
Pregabalin is usually started at a low dose and increased over one to two weeks based on how well it’s working and how well you tolerate it. Starting doses are typically 150 mg per day, split into two or three doses. The target and maximum doses vary by condition:
- Diabetic nerve pain: up to 300 mg per day. Higher doses aren’t recommended because side effects increase without much added benefit.
- Postherpetic neuralgia: 150 to 600 mg per day, with the higher end reserved for patients who don’t respond adequately after two to four weeks at 300 mg.
- Spinal cord injury pain: 150 to 600 mg per day.
- Fibromyalgia: 300 to 450 mg per day. Doses above 450 mg aren’t recommended.
- Partial-onset seizures (adults): up to 600 mg per day.
People with reduced kidney function typically need lower doses, since pregabalin is cleared almost entirely through the kidneys. Your prescriber will adjust based on how well your kidneys are filtering.